TherapeuticsMD, Inc. (TXMD): Price and Financial Metrics

TherapeuticsMD, Inc. (TXMD): $2.05

0.03 (-1.44%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add TXMD to Watchlist
Sign Up

TXMD Price/Volume Stats

Current price $2.05 52-week high $4.35
Prev. close $2.08 52-week low $1.84
Day low $2.02 Volume 10,800
Day high $2.09 Avg. volume 18,679
50-day MA $2.05 Dividend yield N/A
200-day MA $2.41 Market Cap 23.64M

TXMD Stock Price Chart Interactive Chart >


TherapeuticsMD, Inc. (TXMD) Company Bio


TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company was founded in 2008 and is based in Boca Raton, Florida.


TXMD Latest News Stream


Event/Time News Detail
Loading, please wait...

TXMD Latest Social Stream


Loading social stream, please wait...

View Full TXMD Social Stream

Latest TXMD News From Around the Web

Below are the latest news stories about THERAPEUTICSMD INC that investors may wish to consider to help them evaluate TXMD as an investment opportunity.

TherapeuticsMD Announces Third Quarter 2023 Financial Results

BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.

Yahoo | November 14, 2023

TherapeuticsMD Announces Second Quarter 2023 Financial Results

BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.

Yahoo | August 14, 2023

TherapeuticsMD Announces First Quarter 2023 Financial Results

BOCA RATON, Fla., May 15, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2023.

Yahoo | May 15, 2023

All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy

TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | April 14, 2023

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

BOCA RATON, Fla., April 07, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2022.

Yahoo | April 7, 2023

Read More 'TXMD' Stories Here

TXMD Price Returns

1-mo 0.49%
3-mo -14.58%
6-mo -12.39%
1-year -45.77%
3-year -96.82%
5-year -98.32%
YTD -8.89%
2023 -59.75%
2022 -68.55%
2021 -70.62%
2020 -50.00%
2019 -36.48%

Continue Researching TXMD

Here are a few links from around the web to help you further your research on TherapeuticsMD Inc's stock as an investment opportunity:

TherapeuticsMD Inc (TXMD) Stock Price | Nasdaq
TherapeuticsMD Inc (TXMD) Stock Quote, History and News - Yahoo Finance
TherapeuticsMD Inc (TXMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!